Working to End the HIV Epidemic Through Innovation, Equity, Collaboration & Choice
From Bettina Bauer, Vice President, US HIV Treatment and Prevention, Gilead Sciences In 2022, there were up to 1.2 million ...
Taiwan News13d
Immuno Cure Biotech Presents Promising Results on Phase I Clinical Trial of a Therapeutic HIV DNA Vaccine
Immuno Cure is a clinical stage biotechnology group based in the Hong Kong Science Park, focusing on research and development ...
Nature5y
Natural barrier to HIV-1 entry
Kirchhoff and colleagues undertook the task of systematically screening a haemofiltrate-derived peptide library of over one million small peptides for natural inhibitors of HIV-1 replication and ...
Immuno Cure Biotech Presents Promising Results On Phase I Clinical Trial Of A Therapeutic HIV DNA Vaccine Media Outreach Newswire APAC
HONG KONG SAR - Media OutReach Newswire – 12 November 2024 - Immuno Cure BioTech (" Immuno Cure "), a clinical-stage ...